Revenue, last quarter
$5.4M
−5.3% vs same quarter last year
Net income
$706K
+102.9% vs same quarter last year
EPS, diluted
$0.02
+102% vs same quarter last year
Operating cash flow
−$1.1M
−10.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $26.6M | −$91.7M |
| FY24 | $54.2M | −$57.9M |
| FY23 | $22.8M | −$196.3M |
| FY22 | $18M | $14.2M |
| FY21 | $21.3M | −$100.1M |
| FY20 | $14.3M | −$208.2M |
| FY19 | - | $5.9M |
| FY18 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 24.4% | −230.9% | −345.4% |
| FY24 | 72.4% | −70.7% | −106.8% |
| FY23 | 29.7% | −844.4% | −862% |
| FY22 | −9.4% | −142.4% | 79% |
| FY21 | 54.8% | −511.2% | −469.3% |
| FY20 | 65.5% | −1064% | −1458.4% |
| FY19 | - | - | - |
| FY18 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | −$6.6M |
| FY23 | −$39.7M |
| FY22 | −$143.1M |
| FY21 | −$116.3M |
| FY20 | −$91M |
| FY19 | - |
| FY18 | - |
- Celularity
- Healthcare median
Show the numbers
| Year | Celularity | Healthcare median |
|---|---|---|
| FY25 | −345.4% | −30.6% |
| FY24 | −106.8% | −47% |
| FY23 | −862% | −58% |
| FY22 | 79% | −80.4% |
| FY21 | −469.3% | −71.9% |
| FY20 | −1458.4% | −62.2% |
| FY19 | - | −46.3% |
| FY18 | - | −49.6% |